SCHEMBL22901588

SCHEMBL22901588

COc1cccc(COc2cc(C)cc3ccc(Cl)nc23)c1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAOB P27338 7/20 0.51
MAPT P10636 1/20 0.51
HTT P42858 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
ABCB1 P08183 3/20 0.46
HTR1A P08908 2/20 0.46
DRD2 P14416 2/20 0.46
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
MRGPRX4 Q96LA9 1/20 0.44
SLC6A4 P31645 1/20 0.43
PDE4A P27815 2/20 0.43
PDE4B Q07343 2/20 0.43
PDE4C Q08493 2/20 0.43
PDE4D Q08499 2/20 0.43
GCK P35557 1/20 0.43
IDO1 P14902 1/20 0.43
AGXT P21549 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22901568 0.86 MAPT (0.54) MAOBMAPTHTTSMN1; SMN2ABCB1
SCHEMBL22901549 0.83 MAPT (0.48) MAOBMAPTHTTSMN1; SMN2ABCB1
SCHEMBL22901571 0.83 MAPT (0.48) MAOBMAPTHTTSMN1; SMN2ABCB1
SCHEMBL22901565 0.82 MAPT (0.47) MAOBMAPTHTTSMN1; SMN2ABCB1
SCHEMBL22901542 0.82 MAPT (0.47) MAOBMAPTHTTSMN1; SMN2ABCB1
SCHEMBL22901579 0.80 MAPT (0.46) MAOBMAPTHTTSMN1; SMN2ABCB1
SCHEMBL22901548 0.79 MAPT (0.45) MAOBMAPTHTTSMN1; SMN2ABCB1
SCHEMBL22901577 0.79 MAOB (0.46) MAOBMAPTHTTSMN1; SMN2ABCB1
SCHEMBL22901581 0.77 MAPT (0.45) MAOBMAPTHTTSMN1; SMN2ABCB1
SCHEMBL3271562 0.77 MAOB (0.55) MAOBMAPTHTTSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021008588-A1 CLASS OF PYRIMIDINE QUINOLINE DERIVATIVES AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 广州新民培林医药科技有限公司 2021-01-21 WO disclosed